Skip to main content

ADVERTISEMENT

sirolimus

Original Contribution
02/21/2024

Mehdi Madanchi, MD1,2; Matthias Bossard, MD1,2; Irena Majcen, PhD1,2; Giacomo M. Cioffi, MD1,3; Francesco Ferraro, MD4; Eleonora Gnan, MD1,5; Varis Gjergjizi, MD1; Yuan Zhi, MD1; Vanessa Bade, BSc1,6; Mathias Wolfrum, MD1; Federico Moccetti, MD1; Stefan Toggweiler, MD1; Adrian Attinger-Toller, MD1; Florim Cuculi, MD1,2

Mehdi Madanchi, MD1,2; Matthias Bossa...
The study aimed to describe the safety and long-term outcomes of patients with coronary chronic total occlusions undergoing percutaneous coronary interventions with the latest generation of drug-coated balloons vs novel drug-eluting stents.
The study aimed to describe the safety and long-term outcomes of patients with coronary chronic total occlusions undergoing percutaneous coronary interventions with the latest generation of drug-coated balloons vs novel drug-eluting stents.
The study aimed to describe the...
02/21/2024
Journal of Invasive Cardiology
Original Research
09/05/2008
The sirolimus-eluting stent has demonstrated its angiographic and clinical efficacy in the suppression of coronary neointimal hyperplasia in a number of randomized clinical trials. Observational studies have supported the trial results in...
The sirolimus-eluting stent has demonstrated its angiographic and clinical efficacy in the suppression of coronary neointimal hyperplasia in a number of randomized clinical trials. Observational studies have supported the trial results in...
The sirolimus-eluting stent has...
09/05/2008
Vascular Disease Management